Five things for pharma marketers to know Moderna’s investigational vaccine for respiratory syncytial virus is 84% effective against the lower respiratory tract illness linked with the virus, according to phase 3 study...
Latest articles
Five things for pharma marketers to know for Thursday morning
Five things for pharma marketers to know The Supreme Court agreed to review a lower court decision that would make mifepristone, the commonly used abortion pill, less accessible. Poison control centers across the U.S...
November 2023 Recap: Drug Pipeline Updates
November 2023 Recap: Drug Pipeline Updates The table below is a review of notable updates that occurred in November 2023 for investigational products in development (not an inclusive list). Drug Pharmacologic Class...
EC approves Pfizer’s Elrexfio for relapsed and refractory multiple myeloma
EC approves Pfizer’s Multiple Myeloma Drug Elrexfio Pfizer has announced that the European Commission (EC) has granted conditional marketing authorisation for Elrexfio (elranatamab) for the treatment of adult...
10 Outstanding Marketing Campaigns from 2023
10 Outstanding Marketing Campaigns from 2023 Reviewing successful digital marketing campaigns can generate ideas and strategies for your own brand. Here is a list of outstanding marketing campaigns from established...
FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease
FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene...
